Medifast, Inc. Announces Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Medifast (MED) Tops Q2 EPS by 65c
August 4, 2021 4:46 PM EDTMedifast (NYSE: MED) reported Q2 EPS of $3.96, $0.65 better than the analyst estimate of $3.31. Revenue for the quarter came in at $394.2 million versus the consensus estimate of $358.45 million.
GUIDANCE:
Medifast sees Q3 2021 EPS of $12.70-$14.17, versus the consensus of $13.80. Medifast sees Q3 2021... More
